Marlène Thomas
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Oncology 16
- HER2/EGFR in Cancer Research 10
- Cancer Diagnosis and Treatment 3
-
- Monoclonal and Polyclonal Antibodies Research 8
- Co-authors
- Feng-yi Feng (1 shared paper)Astrid Kiermaier (1 shared paper)Timothy Price (1 shared paper)Oliver Stoß (1 shared paper)Yung‐Jue Bang (1 shared paper)Shunchang Jiao (1 shared paper)Julie Hill (1 shared paper)Josef Rüschoff (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Clinical Cancer Research (2 papers)The Oncologist (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)PROTEOMICS (2 papers)
- Partner nations
- SwitzerlandGermanyFrance
In The Last Decade
Marlène Thomas
30 papers receiving 1.1k citations
Marlène Thomas's Hit Papers
Peers
Comparison fields: 5 of 94
- Oncology 627
- Gastroenterology 85
- Cancer Research 203
- Pulmonary and Respiratory Medicine 402
- Radiology, Nuclear Medicine and Imaging 278
Countries citing papers authored by Marlène Thomas
This map shows the geographic impact of Marlène Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlène Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlène Thomas more than expected).
Fields of papers citing papers by Marlène Thomas
This network shows the impact of papers produced by Marlène Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlène Thomas. The network helps show where Marlène Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Marlène Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer Hit paper breakdown → | 2014 | 426 |
| 2 | 2014 | 158 | |
| 3 | 2013 | 78 | |
| 4 | 2017 | 57 | |
| 5 | 2013 | 50 | |
| 6 | 2014 | 46 | |
| 7 | 2020 | 44 | |
| 8 | 2021 | 38 | |
| 9 | 2022 | 36 | |
| 10 | 2022 | 27 | |
| 11 | 2005 | 21 | |
| 12 | 2008 | 15 | |
| 13 | 2013 | 13 | |
| 14 | 2015 | 13 | |
| 15 | 2007 | 12 | |
| 16 | 2014 | 7 | |
| 17 | 2015 | 7 | |
| 18 | 2006 | 7 | |
| 19 | 2013 | 7 | |
| 20 | 2013 | 7 |
About Marlène Thomas
Marlène Thomas is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Pathology and Forensic Medicine and Education, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Cancer Genomics and Diagnostics (4 papers), Teacher Education and Leadership Studies (4 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Diagnosis and Treatment (3 papers), Advanced Biosensing Techniques and Applications (3 papers) and Tumors and Oncological Cases (3 papers). The work is most often cited by research in Oncology (627 citations), Gastroenterology (85 citations), Cancer Research (203 citations), Pulmonary and Respiratory Medicine (402 citations) and Radiology, Nuclear Medicine and Imaging (278 citations). Marlène Thomas has collaborated with scholars based in Switzerland, Germany and France. Frequent co-authors include Feng-yi Feng, Astrid Kiermaier, Timothy Price, Oliver Stoß, Yung‐Jue Bang, Shunchang Jiao, Julie Hill, Josef Rüschoff, Keun-Wook Lee and Vivian Ng. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, The Oncologist, Cancer Chemotherapy and Pharmacology and PROTEOMICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.